Guardant Health
GH
#2472
Rank
HK$45.20 B
Marketcap
HK$365.91
Share price
-0.49%
Change (1 day)
94.94%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of January 2025 (TTM): 8.39

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -96.6. At the end of 2024 the company had a P/S ratio of 4.07.

P/S ratio history for Guardant Health from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.07-30.16%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
14.2 69.85%๐Ÿ‡บ๐Ÿ‡ธ USA
2.81-66.45%๐Ÿ‡บ๐Ÿ‡ธ USA